School Of Medicine Basic Sciences
-
Kidney Disease Research – Original
Kidney Disease Vanderbilt School of Medicine’s Basic Sciences investigators study kidney cancer and kidney disease from molecules to patients. Teams link genomics, epigenetics, and metabolism to clear cell renal cell carcinoma initiation, therapy resistance, and tumor-immune microenvironment. Researchers build organoid, CRISPR, and mouse models to test pathways and identify… Read MoreJan. 29, 2026
-
Gallbladder Disease Research – Original
Gallbladder Disease Research Vanderbilt School of Medicine’s Basic Sciences researchers study gallbladder disease by probing the fundamental biology behind gallstone formation and biliary inflammation. Work commonly integrates cell and animal models with human biospecimens. Investigators explore genetic and environmental risk factors, including diet and the gut-liver-biliary axis, and apply… Read MoreJan. 29, 2026
-
Stomach Disease Research – Original
Stomach Disorders Vanderbilt School of Medicine basic science researchers study stomach (gastric) cancer by uncovering the molecular and cellular mechanisms that drive tumor initiation, progression, and treatment resistance. Work spans cancer genetics and epigenetics, oncogenic signaling, metabolism, and interactions with the tumor microenvironment and immune system. Many labs use… Read MoreJan. 28, 2026
-
Liver Disease Research
Liver Disease Liver disease affects millions globally, with causes including fatty liver (MASLD), viral hepatitis (HCV/HBV), alcohol, and obesity, leading to significant mortality (2M deaths/year globally) and disability. Vanderbilt University School of Medicine Basic Sciences researchers investigate the molecular and cellular mechanisms underlying human liver diseases. Their work aims… Read MoreJan. 27, 2026
-
Liver Disease Research – Original
Liver Disease Liver disease affects millions globally, with causes including fatty liver (MASLD), viral hepatitis (HCV/HBV), alcohol, and obesity, leading to significant mortality (2M deaths/year globally) and disability. Vanderbilt University School of Medicine Basic Sciences researchers investigate the molecular and cellular mechanisms underlying human liver diseases. Their work aims… Read MoreJan. 25, 2026
-
Heart Disease Research – Original
Heart Disease Vanderbilt University School of Medicine Basic Sciences researchers are investigating the heart at its foundations, from the molecular signals that control contraction and rhythm to the genetic and cellular pathways that drive atherosclerosis, inflammation, and heart failure. This bench-level insight fuels the next generation of diagnostics and… Read MoreJan. 22, 2026
-
Colon Diseases Research
Colonic Diseases Vanderbilt scientists are advancing colon disease research by bringing together experts in gastroenterology, oncology, immunology, genetics, and data science to better understand how conditions such as inflammatory bowel disease and colorectal cancer develop and progress. Their work spans the full pipeline-from identifying risk factors and molecular pathways… Read MoreJan. 20, 2026
-
Trainee Tribute: Jen Silverman
Meet Jen Silverman, a Ph.D. candidate in the lab of Matthew Tyska in the Department of Cell and Developmental Biology. Read MoreJan. 20, 2026
-
Colon Diseases Research – Original
Colonic Diseases Vanderbilt scientists are advancing colon disease research by bringing together experts in gastroenterology, oncology, immunology, genetics, and data science to better understand how conditions such as inflammatory bowel disease and colorectal cancer develop and progress. Their work spans the full pipeline-from identifying risk factors and molecular pathways… Read MoreJan. 16, 2026
-
Lung Disease Research – Original
Lung Disease Worldwide, chronic respiratory diseases (CRDs) affect hundreds of millions, with COPD and asthma being major burdens, causing millions of deaths annually, driven largely by smoking and air pollution, though age-standardized rates for many CRDs have dropped, absolute numbers rise due to population growth, and pneumonia remains a leading… Read MoreJan. 16, 2026